Stem Cell Therapy for Rheumatoid Arthritis

Stem Cell Therapy for Rheumatoid Arthritis

What is Rheumatoid Arthritis?

Rheumatoid Arthritis (RA) is an autoimmune disease in which the patient’s immune system generates cellular and antibody responses to various components of the joint such as type I collagen. As a result of this immune response, not only does joint destruction occur, but also other secondary complications such as pulmonary fibrosis, renal damage, and even heart damage.

Can stem cells help treat rheumatoid arthritis?

Newly diagnosed rheumatoid arthritis is currently treated with immune suppressive agents such as steroids, methothrexate, cyclosporine, gold, and more recently infliximab (Remicade). Despite inducing temporary improvement, these approaches possess long-term adverse effects due to non-specific inhibition of immune responses. When disease-modifying anti-rheumatic drugs (DMARDs) like methotrexate are not effective, biologics like abatacept (Orencia), adalimumab (Humira) or etanercept (Enbrel) may be recommended. None of these treatments address the issue of damage that has already occurred to the joints or extra-articular tissues.

Even though advancements in rheumatoid arthritis (RA) treatment protocols and introduction of targeted biological therapies have markedly improved patient outcomes, up to 50% of patients still fail to achieve a significant clinical response.

Stem cell therapy has been demonstrated to induce profound healing activity in animals with various forms of arthritis. For example, the company Vet-Stem routinely utilizes stem cells in horses with various joint deformities to accelerate healing. Besides healing of damaged tissues, stem cells have the unique ability to modulate the immune system so as to shut off pathological responses while preserving ability to fight off disease.

Stem cells and specifically, mesenchymal stem cells (MSCs) are programed to receive signals from damaged tissue ans specifically target inflamed tissue, where they lock-on and begin producing powerful anti-inflammatory agents that stops the pain and heals the damaged tissue. These anti-inflammatory mediators act locally and do not suppress the natural immune response of the rest of the patient’s body. Additionally, MSCs induce the production of T-Regulatory Cells, a type of immune cell whose function is to protect the body against immunological self-attack.

Which types of stem cells are used to treat rheumatoid arthritis and how are they collected?

The mesenchymal stem cells we use are recovered from donated umbilical cords following normal, healthy births. Each mother has her medical history screened and is tested for infectious diseases. Proper consent is received from each family prior to donation.

All umbilical cord-derived stem cells are screened for infectious diseases to International Blood Bank Standards before they are cleared for use in patients.

What are the advantages of treating rheumatoid arthritis with allogeneic umbilical cord tissue-derived stem cells?

Since HUCT mesenchymal stem cells are immune system privileged, cell rejection is not an issue and Human Leukocyte Antigen (HLA) matching is not necessary.

High levels of MSCs can be harvested to provide a high level of anti-inflammatory activity, immune modulating capacity, and ability to stimulate regeneration of damaged tissue.

Stem Cells can be administered in high doses typically in the range of 60-90 million Stem Cells via IV infusion.

No need to collect stem cells from the patient’s hip bone or fat under anesthesia, which especially for small children and their parents, can be an unpleasant ordeal.

There is a growing body of evidence showing that umbilical cord-derived mesenchymal stem cells are more robust than mesenchymal stem cells from Bone Marrow Concentrate or Adipose Tissue.

Umbilical cord-derived mesenchymal stem cells also proliferate/differentiate more efficiently than “older” cells, such as those found in the fat and therefore, they are considered to be more “potent”.

No need to administer chemotherapy drugs like Granulocyte-colony stimulating factor (G-CSF or GCSF) to stimulate the bone marrow to produce granulocytes and stem cells and release them into the bloodstream.

Are mesenchymal stem cells approved by the US FDA?

Human umbilical cord tissue-derived mesenchymal stem cells (MSCs) were approved by the United States FDA with the first regulation/guidelines given in November 2017. FDA Commissioner, Scott Gottlieb, MD, has said, “We’re at the beginning of a paradigm change in medicine with the promise of being able to facilitate regeneration of parts of the human body and adult stem cells can generate replacements for cells that are lost to injury or disease. This is no longer the stuff of science fiction. This is the practical promise of modern applications of regenerative medicine.”

How are the stem cells administered for rheumatoid arthritis treatment?

Stem Cells are given by intravenous (IV) infusion over a period of 15 to 30 minutes. Typically each patient receives 60-90 Million Cells per infusion.

For More Information about Stem Cell Therapy

For more detailed information about Stem Cell Therapy for Rheumatoid Arthritis, we encourage you to read/download the entire chapter on stem cell therapy for arthritis from Dr. Niel Riordan’s new book, Stem Cell Therapy: A Rising Tide – How Stem Cells are Disrupting Medicine and Transforming Lives. Click here (FREE PDF)

“Neil takes readers on a riveting journey through the past, present and future of stem cell therapy. His well-researched, educational and entertaining book could change your life. I highly recommend it.” – Tony Robbins, NY Times #1 Bestselling Author

“100 years old will soon become the new 60. Stem cells are a key therapeutic to enable this future. Dr. Riordan’s book is your guide to why this is true and how you will benefit. A must read for anyone who cares about extending their healthy lifespan.” – Peter H. Diamandis, MD; Founder, XPRIZE & Singularity University; Co-Founder, Human Longevity, Inc.; Author of NY Times Best Sellers Abundance and Bold

Research

Author

Dr. Clark H. HansenDr. Clark H. Hansen is a licensed Naturopathic Medical Doctor (N.M.D.) who has been in private practice in Scottsdale, Arizona, since 1986. He is the President and Medical Director of the Hansen Clinic of Natural Medicine, Aesthetics and Mesotherapy. Dr. Hansen is one of the most well respected Naturopathic Physicians in the country and a Diplomat of the World Society of Anti-Aging Medicine.

Stem Cells are the body's Restore or Replace secret weapon. They can change into any type of cell that the body needs to supplement, restore, reconstruct or replace damaged cells, including Joints, Bones, Heart, Muscle, Nerves, Organs & Skin.

Stem Cell Therapy for Strokes may revolutionize how we treat not only stroke, but traumatic brain injury and even neurodegenerative disorders. The notion that once the brain is injured, it doesn't recover, has now been proven false.

It is estimated that at least 27 million people are affected by arthritis in the US, with an estimated total annual cost of $89.1 billion dollars. If you are considering a $50,000 Total Knee Replacement Surgery don't do it without considering the risks.

Today more than 600 million people suffer from chronic obstructive pulmonary disease (COPD) worldwide. Although there is no cure for COPD, recent advancements in cellular therapy have made it possible to not only relieve symptoms, but to promote healing.

Until recently, Bone Marrow and Adipose (fat) were the only methods being used to harvest stem cells. But recent discoveries have shown that Umbilical Cord Tissue provides much higher concentration of Mesenchymal Stem Cells for a lower cost, with a less in